Press Release | Tue Dec 11, 2012 8:32am EST

Results of Pivotal Study (MCL-001) Evaluating REVLIMID in Mantle-Cell Lymphoma Presented at 54th American Society of Hematology Annual Meeting

* Reuters is not responsible for the content in this press release.